Aim Immunotech Inc Receivables Turnover Ratio (AIM), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Aim Immunotech Inc   (NYSEAMER: AIM)
 

Aim Immunotech Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Aim Immunotech Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 53.71, this represents a new company high. This is a clear indication for improving liquidity at Aim Immunotech Inc 's clients. Average receivable collection period, for the Aim Immunotech Inc in Mar 31 2026 quarter, has decreased to 7 days, compared to 27 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 20 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 185, from overall ranking in the fourth quarter 2025 at 3362.

What is Receivable Turnover Ratio?
What is Aim Immunotech Inc Selling?


What is Receivable Turnover Ratio?





AIM Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 37.5 % -53.33 % -25.71 % -50 % -60 %
Receivable Turnover Ratio (TTM) 53.71 13.54 23.58 25.47 30.74
AIM's Total Ranking # 185 # 3362 # 3619 # 3087 # 3425
Accounts Receivable average collection period days 7 27 15 14 12
Seq. Receivable Change - - - - -
Seq. Revenue Change 4.76 % -19.23 % 4 % 56.25 % -64.44 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 21
Overall Market # 185

Receivable Turnover Ratio Statistics
High Average Low
53.71 7.67 -8.46
(Mar 31 2026)   (Sep 30 2022)






Financial Statements
Aim Immunotech Inc 's Accounts Receivable $ 0 Millions Visit AIM's Balance sheet
Aim Immunotech Inc 's Sales TTM $ 0 Millions Visit AIM's Income Statement
Sources of AIM's Revenues Visit AIM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AIM's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AIM's Growth Rates AIM's Roa AIM's Inventory Turnover Ratio AIM's Dividend Comparisons
AIM's Profitability Ratios AIM's Roi AIM's Asset Turnover Ratio AIM's Dividend Growth
AIM's Valuation Ratios AIM's Roe AIM's Financial Strength Ratios AIM's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026

Date modified: 2026-06-22T20:36:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.